Dividend Aristocrats

Dividend Aristocrats Stocks to Watch

It appears that the ongoing coronavirus pandemic is likely to catalyze the next economic downturn, as ongoing closures across numerous sectors globally take their toll. The significant downturn in the stock market serves as a stark indicator that the situation is deteriorating. The S&P 500 has fallen by over 20%, marking a shift to a bear market after an exceptionally long period of bullish trends. In the midst of this aggressive stock market selloff, companies such as Medtronic PLC (NYSE: MDT), Johnson & Johnson (NYSE: JNJ), and Genuine Parts Company (NYSE: GPC) still represent promising options for investors.

The pullback in the stock market might as well have presented an opportunity to buy stocks at highly discounted rates. Some of the stocks worth paying close watch to be those that have solid fundamentals and have consistently raised interest rates for 25 years or more. Dividend Aristocrats and Dividend Kings are the stocks that any investor looking for long-term investment opportunities should play close watch to.

Continue check out our Dividend Stocks news on AlphaBetaStock.com.

Medtronic Dividend Aristocratic

Medtronic PLC (NYSE: MDT) is a dividend Aristocratic that looks like a safe bet, amidst the ongoing sell-off triggered by the COVID-19 pandemic. The fact that the company’s core business revolves around the healthcare industry means it is well-positioned to ride through the current sell-off.

The company develops and distributes device-based medical therapies, commonly used in hospitals by physicians, clinicians, and patients worldwide. With the healthcare industry a buzz of activity amidst the current pandemic, Medtronic should continue to see booming business.

Medtronic should continue to register sales growth as the healthcare industry is projected to grow by 5% to 6%. With the current stock trading at more than 40% below its 52-week high, now may be the best time to buy it at a discount. Similarly, Medtronic boasts of an attractive dividend yield that should excite income-focused investors. The medical device company boasts of a 2.7% dividend yield.

Johnson & Johnson Attractive Dividend Yield

Johnson & Johnson (NYSE:JNJ) is a must-watch for investors looking to gain exposure in the healthcare sector in addition to taking advantage of attractive dividend yield. The company’s core business revolves around the pharmaceutical and consumer staples industries that is at the center of the current standoff triggered by Covid-19.

The company’s Pharma business is at the heart of the company’s bottom line, having generated attractive growth rates in recent years. Demand for the company’s cancer drugs such as Imbruvica should continue to affirm sales growth. The fact that demand for pharmaceutical products is not cyclical affirms the fact that the company will continue to register sales amidst the COVID-19 pandemic.

In addition, Johnson & Johnson’s dividend yield has risen to five years high in recent years. With sales not expected to drop significantly amidst the current standoff in the equity market, the company should be able to safeguard its dividend yield.

Genuine Parts Company (NYSE:GPC) Recession Prospects

Genuine Parts Company (NYSE:GPC) is an ideal pick for investors looking to diversify their portfolio beyond the healthcare sector. The company distributes and sales car parts for buses, trucks, farm vehicles as well as marine equipment.

In case of a recession, demand for new automobiles normally takes a hit. In such a case, Genuine Parts Company looks set to enjoy booming business on people coming for car parts to repair their cars. During a recession, people tend to hang on to their old cars instead of spending more to buy new cars.

Genuine Parts continued to grow its dividend in recent years on customers hanging on to their older cars; therefore fueling demand for car parts. Likewise, the company looks set to navigate the imminent recession with ease as it has done in yesteryears.

Free AlphaBetaStock's Cheat Sheet (No CC)!+ Bonus Dividend Stock Picks

Comments are closed.

Scroll to Top